Literature DB >> 6932473

Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition.

S G Emerson, D B Murphy, R E Cone.   

Abstract

Lactoperoxidase-catalyzed cell surface radioiodination and incorporation of [3H]-leucine were employed to radiolabel H-2K and H-2D antigens of murine spleen cells. The fate of H-2 antigens was monitored by in vitro culture of labeled cells and isolation of labeled antigens from detergent lysates of the cells and culture supernates obtained at different times during culture. H-2Kk antigens were found to be rapidly turned over and shed by CBA/J cells, whereas the turnover of H-2Dk antigens was extremely slow. Analysis of the membrane residence times of surface-labeled H-2K and H-2D antigens on spleen cells from various H-2-congenic and -recombinant strains demonstrated variations in the shedding rates of H-2K and H-2D antigens, which were controlled by genes mapping in the major histocompatibility complex. These variations show a striking correlation with published, genetically controlled quantitative variations in the cytotoxic response of T lymphocytes to chemically modified or virus-infected syngeneic cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6932473      PMCID: PMC2185957          DOI: 10.1084/jem.152.4.783

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Isolation of membrane associated immunoglobulins from T lymphocytes by non-ionic detergents.

Authors:  R E Cone; W C Brown
Journal:  Immunochemistry       Date:  1976-07

2.  Synthesis of surface H-2 alloantigens in murine splenocytes.

Authors:  E S Vitetta; J W Uhr
Journal:  J Immunol       Date:  1975-08       Impact factor: 5.422

3.  Interaction antigens detected by cytotoxic T cells with the major histocompatibility complex as modifier.

Authors:  M J Bevan
Journal:  Nature       Date:  1975-07-31       Impact factor: 49.962

4.  Definition of staphylococcal protein A reactivity for human immunoglobulin G fragments.

Authors:  G Kronvall; D Frommel
Journal:  Immunochemistry       Date:  1970-01

5.  Cell-medicated cytotoxicity against ectromelia virus-infected target cells. III. Role of the H-2 gene complex.

Authors:  I D Gardner; N A Bowern; R V Blanden
Journal:  Eur J Immunol       Date:  1975-02       Impact factor: 5.532

6.  On the role of the H-2 histocompatibility complex in determining the specificity of cytotoxic effector cells sensitized against syngeneic trinitrophenyl-modified targets.

Authors:  J Forman
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

7.  H-2 compatability requirement for T-cell-mediated lysis of target cells infected with lymphocytic choriomeningitis virus. Different cytotoxic T-cell specificities are associated with structures coded for in H-2K or H-2D;.

Authors:  R M Zinkernagel; P C Doherty
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

8.  In vitro cell-mediated immune responses to the male specific(H-Y) antigen in mice.

Authors:  R D Gordon; E Simpson; L E Samelson
Journal:  J Exp Med       Date:  1975-11-01       Impact factor: 14.307

9.  Synthesis, intracellular distribution, and secretion of immunoglobulin and H-2 antigen in muring splenocytes.

Authors:  D Wernet; E S Vitetta; J W Uhr; E A Boyse
Journal:  J Exp Med       Date:  1973-10-01       Impact factor: 14.307

10.  Bifunctional major histocompatibility-linked genetic regulation of cell-mediated lympholysis to trinitrophenyl-modified autologous lymphocytes.

Authors:  A M Schmitt-Verhulst; G M Shearer
Journal:  J Exp Med       Date:  1975-10-01       Impact factor: 14.307

View more
  24 in total

1.  Different rates of HLA class I molecule assembly which are determined by amino acid sequence in the alpha 2 domain.

Authors:  A Hill; M Takiguchi; A McMichael
Journal:  Immunogenetics       Date:  1993       Impact factor: 2.846

2.  Qa gene expression: biosynthesis and secretion of Qa-2 molecules in activated T cells.

Authors:  M J Soloski; J Vernachio; G Einhorn; A Lattimore
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

3.  Aberrancy in immunogenicity and cell-surface expression of H-2 antigens on erythrocytes.

Authors:  I Nakashima; T Yoshida; T Yokochi; K Ohashi; F Nagase; K Isobe; Y Hasegawa; K Ando; R Inagi
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  Restricted blocking of cytotoxic T-cell function by anti-H-2K/D antibodies.

Authors:  H C O'Neill
Journal:  Immunology       Date:  1988-02       Impact factor: 7.397

5.  The induction of cytotoxic T-cell responses with H-2 antigens shed from viable lymphocytes.

Authors:  E Meeusen
Journal:  Immunology       Date:  1987-07       Impact factor: 7.397

6.  Regulatory mechanisms in cell-mediated immune responses. Role of I-J and I-C determinants in the activation of H-2I and H-2K/D alloantigen-specific suppressor T cells.

Authors:  S Rich
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

7.  A factor shed by lymphoblastoid cell lines of HLA-B27 positive patients with ankylosing spondylitis, specifically modifies the cells of HLA-B27 positive normal individuals.

Authors:  P Orban; J S Sullivan; A F Geczy; L I Upfold; N Coulits; H V Bashir
Journal:  Clin Exp Immunol       Date:  1983-07       Impact factor: 4.330

8.  Immune reactions in the eye.

Authors:  C S Foster; R Wetzig
Journal:  Surv Immunol Res       Date:  1982

9.  Monoclonal antibody reveals H-2-linked quantitative and qualitative variation in the expression of a Qa-2 region determinant.

Authors:  J Rucker; M Horowitz; E A Lerner; D B Murphy
Journal:  Immunogenetics       Date:  1983       Impact factor: 2.846

10.  Human interferon-gamma enhances the expression of class I and class II major histocompatibility complex products in neoplastic cells more effectively than interferon-alpha and interferon-beta.

Authors:  A Dolei; M R Capobianchi; F Ameglio
Journal:  Infect Immun       Date:  1983-04       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.